Non-invasive solution for periodontal and peri-implant diseases

Project Information

INPERIO

Grant agreement ID: 812065

DOI 10.3030/812065

Project closed

EC signature date 23 April 2018

Start date 1 May 2018

End date 30 April 2020

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 2 709 751,25

EU contribution € 1 896 825,88

Coordinated by

NANOKER RESEARCH SL
Spain

Objective

Nanoker Research, S.L has identified a potential business in dNanoker Research, S.L has identified a potential business in developing and promoting global dental solutions of the highest quality for patients with periodontal or peri-implant disease, which is the most prevalent form of bone pathology in humans, affecting 50% of the entire adult population. Nanoker has developed an aesthetic, mechanically reliable and tissue friendly all-ceramic dental reconstruction solution at TRL6 that prevents periimplantitis; in 2016, the global market value of dental implants and prosthetics reached 6.175 M€, with an estimated compound annual growth rate (CAGR) of 7-9% for the next few years. Nanoker has the potential to become the only company in the world with an available, long-lasting, non-invasive dental solution for periimplantitis patients. This solution is expected to obtain around 0.49% of the dental implant market share 3 years after project termination, and around 1.13% (133 M€) of the dental implant market share 5 years later. Thus, in only four years, Nanoker could reach a turnover of +47.3 M€ with a production capability of 100,000 implants-abutments/year and an accumulated EBITDA of +33.9 M€ (over four years). To remove the last dental health market barriers it is necessary to make a final investment in terms of product industrialization and certification, as described in this proposal, to become known and worthy to key opinion leaders. In this regard, this project, with a total budget of 4,370,373.75 € covers the expenses related to: a) the successful industrial-scale development of a set of dental prosthetic components made from a coated and highly resistant ceramic nanocomposite; b) performing a Clinical Validation; c) business growth, through two different distribution approaches: an own firm and implant manufacturers with presence in the main markets; and d) the product’s worldwide launch, to put Nanoker at the forefront of the market and industry innovation.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• medical and health sciences › clinical medicine › odontology › dental implantology
• medical and health sciences › clinical medicine › odontology › periodontics

You need to log in or register to use this function

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

NANOKER RESEARCH SL

• Net EU contribution: € 1 896 825,88
• Address: POLIGONO DE OLLONIEGO 5 PARCELLA 22 NAVE 5 ; 33660 Oviedo ; Spain
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Noroeste › Principado de Asturias › Asturias
• Region: Noroeste › Principado de Asturias › Asturias
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 2 709 751,25